Portfolio of Marijuana (Cannabis) Pharma Stocks Traded on the NYSE and NASDAQ
Here is a table of 7 cannabis stocks that are developing cannabis compound medicines.
|7 Cannabis Pharma Stocks|
Stock Returns & Price Chart
Recent Prices &
|Corbus Pharmaceuticals Holdings||CRBP|
|Price data from Quandl as of most recent close.|
To inspect the performance of the Cannabis Pharma Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Quandl.All 7 stocks are included in the portfolio computations. The current value of the portfolio assumes that $1,428.57 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends.
The current value of a $10,000 investment is $9,401. The percent return is -5.99%. The annualized return is -2.71%.
|Return Summary for Cannabis Pharma Stocks|
|Current Value of Investment||$9,401.33|
|Number Profitable Returns||217|
|Percent Profitable Returns||57.41%|
|Number Unprofitable Returns||161|
|Percent Unprofitable Returns||42.59%|
|Profitable to Unprofitable Returns Ratio||1.35|
NOTE: The stocks included in the tables and chart are representative of the industry. They are not recommendations.